These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31974040)

  • 1. Survival improvement and prognostic factors in recent management of extrahepatic cholangiocarcinoma: A single-center study.
    Choe JW; Kim HJ; Kim JS
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):153-156. PubMed ID: 31974040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakamura H; Nakashima A; Sueda T
    J Gastrointest Surg; 2009 Aug; 13(8):1470-9. PubMed ID: 19421824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for inoperable advanced or metastatic cholangiocarcinoma: retrospective analysis of 78 cases in a single center over four years.
    Pracht M; Le Roux G; Sulpice L; Mesbah H; Manfredi S; Audrain O; Boudjema K; Raoul JL; Boucher E
    Chemotherapy; 2012; 58(2):134-41. PubMed ID: 22572213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
    Murakami Y; Uemura K; Sudo T; Hashimoto Y; Kondo N; Nakagawa N; Muto T; Sasaki H; Urabe K; Sueda T
    J Gastrointest Surg; 2013 Aug; 17(8):1429-39. PubMed ID: 23797881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Strategy of Treatment for Mid to Distal Cholangiocarcinoma after Surgical Resection.
    Lee SR; Kim HO; Shin JH
    Am Surg; 2018 Jun; 84(6):820-825. PubMed ID: 29981608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
    Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
    Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic Factors for Survival in Patients with Advanced Intrahepatic Cholangiocarcinoma Treated with Gemcitabine plus Cisplatin as First-Line Treatment.
    Ishimoto U; Kondo S; Ohba A; Sasaki M; Sakamoto Y; Morizane C; Ueno H; Okusaka T
    Oncology; 2018; 94(2):72-78. PubMed ID: 29017161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): a single-institution experience.
    Gusani NJ; Balaa FK; Steel JL; Geller DA; Marsh JW; Zajko AB; Carr BI; Gamblin TC
    J Gastrointest Surg; 2008 Jan; 12(1):129-37. PubMed ID: 17851723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL; Vining CC; Roses RE; Maggino L; Lee MK; Drebin JA; Fraker DL; Vollmer CM; Datta J
    Ann Surg Oncol; 2017 Dec; 24(13):3926-3933. PubMed ID: 28952140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma.
    Gonzalez-Carmona MA; Bolch M; Jansen C; Vogt A; Sampels M; Mohr RU; van Beekum K; Mahn R; Praktiknjo M; Nattermann J; Trebicka J; Branchi V; Matthaei H; Manekeller S; Kalff JC; Strassburg CP; Weismüller TJ
    Aliment Pharmacol Ther; 2019 Feb; 49(4):437-447. PubMed ID: 30637783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.
    Toyota K; Murakami Y; Kondo N; Uemura K; Nakagawa N; Takahashi S; Sueda T
    Ann Surg Oncol; 2018 May; 25(5):1202-1210. PubMed ID: 29492748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma.
    Fernández-Ruiz M; Guerra-Vales JM; Colina-Ruizdelgado F
    World J Gastroenterol; 2009 Nov; 15(42):5279-86. PubMed ID: 19908335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS; Zhang Q; Sada YH; Chai C; Curley SA; Massarweh NN
    Cancer; 2018 Jan; 124(1):74-83. PubMed ID: 28841223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
    Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
    BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of hepatitis B virus infection in intrahepatic cholangiocarcinoma treated with first-line gemcitabine plus cisplatin.
    Chae H; Cho H; Yoo C; Kim KP; Jeong JH; Chang HM; Kang J; Lee HC; Lim YS; Kim KM; Shim JH; Lee SS; Park DH; Song TJ; Hwang S; Song GW; Moon DB; Lee YJ; Lee JH; Ryoo BY
    Int J Biol Markers; 2018 Nov; 33(4):432-438. PubMed ID: 29874985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined High-Dose Radiotherapy with Sequential Gemcitabine-Cisplatin Based Chemotherapy Increase the Resectability and Survival in Locally Advanced Unresectable Intrahepatic Cholangiocarcinoma: A Multi-institutional Cohort Study.
    Im JH; Yu JI; Kim TH; Kim TG; Kim JW; Seong J
    Cancer Res Treat; 2024 Jul; 56(3):838-846. PubMed ID: 38186240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis.
    Schweitzer N; Weber T; Kirstein MM; Fischer M; Kratzel AM; Reineke-Plaaß T; Lehner F; Manns MP; Vogel A
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1347-1355. PubMed ID: 28314929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoropyrimidines plus cisplatin versus gemcitabine/gemcitabine plus cisplatin in locally advanced and metastatic biliary tract carcinoma - a retrospective study.
    Croitoru A; Gramaticu I; Dinu I; Gheorghe L; Alexandrescu S; Buica F; Luca I; Becheanu G; Herlea V; Simionov I; Hrehoret D; Lupescu I; Popescu I; Diculescu M
    J Gastrointestin Liver Dis; 2012 Sep; 21(3):277-84. PubMed ID: 23012669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.